G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients.

Janna Krol; Stefan Paepke; Volker Jacobs; Daniela Paepke; Uta Euler; Marion Kiechle; Nadia Harbeck

doi:10.1159/000091616

G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients.

Janna Krol, Stefan Paepke, Volker Jacobs (Co-author), Daniela Paepke, Uta Euler, Marion Kiechle, Nadia Harbeck

Research output: Contribution to journal › Review article › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	171-178
Journal	ONKOLOGIE
Volume	29
Issue number	4
DOIs	https://doi.org/10.1159/000091616
Publication status	Published - 2006

Keywords

COLONY-STIMULATING FACTOR
PHASE-III TRIAL
RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY
SURGICAL ADJUVANT BREAST
FIRST-LINE CHEMOTHERAPY
HIGH-DOSE EPIRUBICIN
RANDOMIZED-TRIAL
1ST-LINE CHEMOTHERAPY
BIWEEKLY DOCETAXEL
CLINICAL-PRACTICE

Access to Document

10.1159/000091616

Cite this

Krol, J., Paepke, S., Jacobs, V., Paepke, D., Euler, U., Kiechle, M., & Harbeck, N. (2006). G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients. ONKOLOGIE , 29(4), 171-178. https://doi.org/10.1159/000091616

Krol, Janna ; Paepke, Stefan ; Jacobs, Volker et al. / G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients. In: ONKOLOGIE 2006 ; Vol. 29, No. 4. pp. 171-178.

@article{f340672307c543069ceff9127761057e,

title = "G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients.",

keywords = "COLONY-STIMULATING FACTOR, PHASE-III TRIAL, RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY, SURGICAL ADJUVANT BREAST, FIRST-LINE CHEMOTHERAPY, HIGH-DOSE EPIRUBICIN, RANDOMIZED-TRIAL, 1ST-LINE CHEMOTHERAPY, BIWEEKLY DOCETAXEL, CLINICAL-PRACTICE",

author = "Janna Krol and Stefan Paepke and Volker Jacobs and Daniela Paepke and Uta Euler and Marion Kiechle and Nadia Harbeck",

year = "2006",

doi = "10.1159/000091616",

language = "English",

volume = "29",

pages = "171--178",

journal = "ONKOLOGIE ",

issn = "0378-584X",

number = "4",

}

Krol, J, Paepke, S, Jacobs, V, Paepke, D, Euler, U, Kiechle, M & Harbeck, N 2006, 'G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients.', ONKOLOGIE , vol. 29, no. 4, pp. 171-178. https://doi.org/10.1159/000091616

G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients. / Krol, Janna; Paepke, Stefan; Jacobs, Volker (Co-author) et al.
In: ONKOLOGIE , Vol. 29, No. 4, 2006, p. 171-178.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients.

AU - Krol, Janna

AU - Paepke, Stefan

AU - Jacobs, Volker

AU - Paepke, Daniela

AU - Euler, Uta

AU - Kiechle, Marion

AU - Harbeck, Nadia

PY - 2006

Y1 - 2006

KW - COLONY-STIMULATING FACTOR

KW - PHASE-III TRIAL

KW - RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY

KW - SURGICAL ADJUVANT BREAST

KW - FIRST-LINE CHEMOTHERAPY

KW - HIGH-DOSE EPIRUBICIN

KW - RANDOMIZED-TRIAL

KW - 1ST-LINE CHEMOTHERAPY

KW - BIWEEKLY DOCETAXEL

KW - CLINICAL-PRACTICE

U2 - 10.1159/000091616

DO - 10.1159/000091616

M3 - Review article

C2 - 16601374

SN - 0378-584X

VL - 29

SP - 171

EP - 178

JO - ONKOLOGIE

JF - ONKOLOGIE

IS - 4

ER -

Krol J, Paepke S, Jacobs V, Paepke D, Euler U, Kiechle M et al. G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients. ONKOLOGIE . 2006;29(4):171-178. doi: 10.1159/000091616